Fonterra JV to buy lactose business from Dutch partner Royal FrieslandCampina

Fonterra Cooperative Group, the world’s biggest dairy exporter, said its joint venture with Royal FrieslandCampina will acquire the Dutch milk products group’s pharmaceutical lactose business for about $106 million.

Fonterra’s share of the purchase price is $53 million, the cooperative said in a statement today. The DMV-Fonterra Excipients JV will acquire the FrieslandCampina Domo-Pharma unit subject to regulatory approvals in a deal expected by March, it said.

The transaction will add value to Fonterra by creating a larger scale pharmaceutical lactose business, said Andrei Mikhalevsky, managing director for ingredients. The deal would combine the two companies’ R&D capabilities, he said. 

Businesswire.co.nz

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

TWL - Share Purchase Plan Results
GMT revaluation, unit buyback and proposed structure update
Devon Funds Morning Note - 17 February 2026
CEN - Contact successfully completes NZ$450m Placement
February 17th Morning Report
PFI - Divestments
CEN offers to purchase remaining 25% of King Country Energy
February 16th Morning Report
SkyCity Appoints Chief Financial Officer
February 13th Morning Report